Sokol,
Thank you for these follow on comments - spot on, imo.
For clarification, I never suggested that the FDA acted selflessly, only that they were now able to capitalize on the “bribe money” or “pay offs” or “kick backs” which they never succumbed to with any of the previous plaque attack drugs.
I believe that I specifically stated that the FDA was now free to get their “take” for approving a reprehensible drug as long as they did it out in the open to demonstrate the wholesale graft and rule bending that it would take - regardless of how unseemly, simply because they knew that another drug and possibly others will follow which actually have merit in the fight against Alz. The game board is open for all the useful drugs which may come along as the old guard will not be heard from again.
I believe that was misconstrued due to lack of sufficient assiduity in keeping one’s eye on the ball.
…and in that sleep of death what dreams may come, ay, there’s the rub…
I think the rub came from “dreams” of what I postulated, as opposed to reality.
Equal esteem for the insightful posts you always contribute - thank you for your time.
Bio
News 
Market Data 
Discover 
AI
